FRAMEWORK AGREEMENTFramework Agreement • September 8th, 2004 • Immune Response Corp • Biological products, (no disgnostic substances)
This Framework Agreement is entered into on August 16, 2004 between The Immune Response Corporation (“IRC”) and NovaRx Corporation (“NovaRx”).
NOVATION AGREEMENTNovation Agreement • September 8th, 2004 • Immune Response Corp • Biological products, (no disgnostic substances) • California
THIS NOVATION AGREEMENT (this “Agreement”) is made as of August 16, 2004 (the “Novation Date”) by and among THE IMMUNE RESPONSE CORPORATION, a Delaware corporation, having a place of business located at 5931 Darwin Court, Carlsbad, California 92008 (“IRC”), and NOVARX CORPORATION, a Delaware corporation, having a place of business located at 8866 Caminito Primo Vera, La Jolla, California 92037 (“NovaRx”), and MASAYOSHI NAMBA, M.D., an individual, having a place of business at The Okayama Medical Foundation, Okayama University Medical School, 2-5-1 Shikata, Okayama 700-8558, Japan (“Dr. Namba”).
NOVATION AGREEMENTNovation Agreement • September 8th, 2004 • Immune Response Corp • Biological products, (no disgnostic substances) • California
THIS NOVATION AGREEMENT (this “Agreement”) is made as of August 16, 2004 (the “Novation Date”) by and among THE IMMUNE RESPONSE CORPORATION, a Delaware corporation, having a place of business located at 5931 Darwin Court, Carlsbad, California 92008 (“IRC”), and NOVARX CORPORATION, a Delaware corporation, having a place of business located at 8866 Caminito Primo Vera, La Jolla, California 92037 (“NovaRx”), and SIDNEY KIMMEL CANCER CENTER, a California nonprofit corporation, having a place of business located at 3099 Science Park Road, San Diego, California 92121 (“SKCC”).
